Lotilaner

CHEMBL3707310 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
596.8 g/mol
LogP
6.6
Phase
4

This isoxazoline compound kills parasites like fleas and ticks on companion animals by blocking insect-specific chloride channels, causing paralysis and death of the parasites. It is used in oral or ophthalmic formulations for veterinary and some human parasitic infections.

分子量

596.8000 g/mol

LogP

6.60

TPSA

108.00 Ų

リピンスキーの五則

不適合

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cc1cc(C2=NO[C@@](c3cc(Cl)c(Cl)c(Cl)c3)(C(F)(F)F)C2)sc1C(=O)NCC(=O)NCC(F)(F)F

InChI

InChI=1S/C20H14Cl3F6N3O3S/c1-8-2-13(36-16(8)17(34)30-6-14(33)31-7-19(24,25)26)12-5-18(35-32-12,20(27,28)29)9-3-10(21)15(23)11(22)4-9/h2-4H,5-7H2,1H3,(H,30,34)(H,31,33)/t18-/m0/s1

Molecular Formula

C20H14Cl3F6N3O3S

HBD / HBA

2 / 11

回転可能結合数

6

重原子数

36

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

This isoxazoline compound kills parasites like fleas and ticks on companion animals by blocking insect-specific chloride channels, causing paralysis and death of the parasites. It is used in oral or ophthalmic formulations for veterinary and some human parasitic infections.

Yes, Lotilaner is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3707310. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 76959255. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.